Tarigan TJE, Yunir E, Subekti I, et al. Profile and analysis of chronic diabetes complications in the Outpatient Diabetes Clinic of Cipto Mangunkusumo Hospital, Jakarta. Med J Indones. 2015;24(3):156-162.

Mihardja L, Delima D, Massie RGA, et al. Prevalence of kidney dysfunction in diabetes mellitus and associated risk factors among productive age Indonesians. J Diabetes Metab Disord. 2018;17(1):53-61

Wilmot E, Idris I. Early onset type 2 diabetes: risk factors, clinical impact, and management. Ther Adv Chronic Dis. 2014;5(6):234-244

Shafiee G, Keshtkar A, Soltani A, et al. Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies. J Diabetes Metab Disord. 2017;16:21

Indirayani HW, Widjajanti N, Firdausi H. Hubungan defisiensi kalsidiol serum dan derajat sarkopenia pada komunitas usia lanjut di Surabaya. J Penyakit Dalam Indonesia. 2020;7(1):29-33

Bae EJ, Kim YH. Factors affecting sarcopenia in Korean adults by age groups.

Osong Public Health Res Perspect. 2017;8(3):169-178

Jung HN, Jung CH, Hwang YC. Sarcopenia in youth. Metabolism. 2023;144:155557

Shimabukuro M. Leptin resistance and lipolysis of white adipose tissue: an implication to ectopic fat disposition and its consequences. J Atheroscler Thromb. 2017;24(11):1088-1089.

Chen L, Chen R, Wang H, et al. Mechanisms linking inflammation to insulin resistance. Int J Endocrinol. 2015;2015:508409

Zhu J, Guo B, Gan X, et al. Association of circulating leptin and adiponectin with periodontitis: a systematic review and meta-analysis. BMC Oral Health. 2017;17(1):104.

Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300-307.e2

Kim TN, Park MS, Yang SJ, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS) [published correction appears in Diabetes Care. 2010;33(10):2294]. Diabetes Care. 2010;33(7):1497-1499. doi:10.2337/dc09-2310

Lin YL, Wang CH, Lai YH, et al. Negative correlation between leptin serum levels and sarcopenia in hemodialysis patients. Int J Clin Exp Pathol. 2018;11(3):1715- 23.

Hsu YT, Lin JY, Lin CJ, et al. Association of possible sarcopenia or sarcopenia with body composition, nutritional intakes, serum vitamin D levels, and physical activity among patients with type 2 diabetes mellitus in Taiwan. Nutrients. 2023;15(18):3892.

Kao TW, Peng TC, Chen WL, et al. Higher serum leptin levels are associated with a reduced risk of sarcopenia but a higher risk of dynapenia among older adults. J Inflamm Res. 2021;14:5817-25.

Yang ZY, Chen WL. Examining the association between serum leptin and sarcopenic obesity. J Inflamm Res. 2021;14:3481-7. doi:10.2147/JIR.S322420

Shimokata H, Ando F, Otsuka R. Longitudinal association between serum adiponectin and sarcopenia in a community-living population. Innov Aging. 2017;1(Suppl 1):1125. doi:10.1093/geroni/igx004.4114

Komici K, Dello Iacono A, De Luca A, et al. Adiponectin and sarcopenia: a systematic review with meta-analysis. Front Endocrinol (Lausanne). 2021;12:633117.

Li CW, Yu K, Shyh-Chang N, et al. Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention. J Cachexia Sarcopenia Muscle. 2019;10(3):586-600.

Can B, Kara O, Kizilarslanoglu MC, et al. Serum markers of inflammation and oxidative stress in sarcopenia. Aging Clin Exp Res. 2017;29:745-52.

Hamrick MW, Herberg S, Arounleut P, et al. The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem Biophys Res Commun. 2010;400(3):379-83.

Minniti G, Pescinini-Salzedas LM, Minniti GAdS, et al. Organokines, sarcopenia, and metabolic repercussions: the vicious cycle and the interplay with exercise. Int J Mol Sci. 2022;23(21):13452.

Park SW, Goodpaster BH, Strotmeyer ES, et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007;30(6):1507-12.

Morigny P, Houssier M, Mouisel E, et al. Adipocyte lipolysis and insulin resistance. Biochimie. 2016;125:259-66.

Kohara K, Ochi M, Tabara Y, et al. Leptin in sarcopenic visceral obesity: possible link between adipocytes and myocytes. PLoS One. 2011;6(9):e24633.

Bungau S, Behl T, Tit DM, et al. Interactions between leptin and insulin resistance in patients with prediabetes, with and without NAFLD. Exp Ther Med. 2020;20(6):197.

Liu C, Feng X, Li Q, et al. Adiponectin, TNF-α, and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis. Cytokine. 2016;86:100-9.

Liao PJ, Ting MK, Wu IW, et al. Higher leptin-to-adiponectin ratio strengthens the association between body measurements and the occurrence of type 2 diabetes mellitus. Front Public Health. 2021;9:678-81.

Al-Hamodi Z, Al-Habori M, Al-Meeri A, Saif-Ali R. Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus. Diabetol Metab Syndr. 2014;6(1):99.